Current medical therapies for chronic stable angina pectoris do not always render patients free of symptoms and may not be well tolerated. Xanthine oxidase inhibition with drugs such as allopurinol might be a promising new approach to treat these patients.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The Role of Ivabradine in the Management of Angina Pectoris
Cardiovascular Drugs and Therapy Open Access 30 July 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fox, K. et al. Guidelines on the management of stable angina pectoris: executive summary. The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur. Heart J. 27, 1341–1381 (2006).
Lloyd-Jones, D. et al. Executive summary: heart disease and stroke statistics 2010 update: a report from the American Heart Association. Circulation 121, 948–954 (2010).
Noman, A., Ang, D. S., Ogston, S., Lang, C. C. & Struthers, A. D. Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial. Lancet 375, 2161–2167 (2010).
Gislason, G. H. et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur. Heart J. 27, 1153–1158 (2006).
Tardif, J. C. et al. for the ASSOCIATE Study Investigators. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial. Eur. Heart J. 30, 540–548 (2009).
Weintraub, W. S. et al. for the COURAGE Trial Research Group. Effect of PCI on quality of life in patients with stable coronary disease. N. Engl. J. Med. 359, 677–687 (2008).
Serruys, P. W. et al. for the Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N. Engl. J. Med. 344, 1117–1124 (2001).
Ciapponi, A., Pizarro, R. & Harrison, J. Trimetazidine for stable angina. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD003614. doi: 10.1002/14651858.CD003614.pub2 (2005).
Chaitman, B. R. et al. for the CARISA Investigators. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA 291, 309–316 (2004).
Gavin, A. D. & Struthers, A. D. Allopurinol reduces B-type natriuretic peptide concentrations and hemoglobin but does not alter exercise capacity in chronic heart failure. Heart 91, 749–753 (2005).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
K. M. Fox is a consultant for, is in the speaker's bureau of, and received research support from Servier Laboratories. R. de Silva declares no competing interests.
Rights and permissions
About this article
Cite this article
de Silva, R., Fox, K. Xanthine oxidase inhibition for relief of angina pectoris. Nat Rev Cardiol 7, 603–604 (2010). https://doi.org/10.1038/nrcardio.2010.143
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2010.143
This article is cited by
-
The Role of Ivabradine in the Management of Angina Pectoris
Cardiovascular Drugs and Therapy (2016)